Krka Increases Sales by 12 Percent in January-September Period

Novo Mesto, 18 October - Slovenian drug maker Krka sold products worth SIT 58bn (EUR 253.5m) in the first nine months of this year, up 12 percent from the same period last year. Sales on the domestic market increased by 11 percent. Selling 20 percent of all of its products at home, Slovenia has remained Krka's largest single market. Its results are in line with this year's plans, said the company.